An HNF4α antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BI-6015

Item No. 12032

Technical Information
Formal Name
2-methyl-1-[(2-methyl-5-nitrophenyl)sulfonyl]-1H-benzimidazole
CAS Number
93987-29-2
Molecular Formula
C15H13N3O4S
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 16 mg/mlDMSO: 14 mg/mlDMSO:PBS (pH 7.2) (1:10): 0.09 mg/ml
λmax
245 nm
SMILES
CC1=NC2=CC=CC=C2N1S(C3=C(C)C=CC([N+]([O-])=O)=C3)(=O)=O
InChi Code
InChI=1S/C15H13N3O4S/c1-10-7-8-12(18(19)20)9-15(10)23(21,22)17-11(2)16-13-5-3-4-6-14(13)17/h3-9H,1-2H3
InChi Key
ILVCPQPMRPHZSG-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Hepatocyte nuclear factor 4α (HNF4α) is a nuclear receptor transcription factor that controls the expression of many genes including those involved in glucose and lipid homeostasis and maintenance of epithelial differentiation. BI-6015 is a small molecule antagonist of HNF4α that has been shown to repress the expression of known HNF4α target genes.1 At concentrations up to 20 μM, BI-6015 has been shown to reduce endogenous insulin gene expression by as much as 50-fold in T6PNE cells.1 The hepatocytes from livers of mice injected with 10 and 30 mg/kg BI-6015 exhibit marked, dose-dependent fat accumulation (steatosis).1 Additionally, at a daily dose of 30 mg/kg, BI-6015 induces apoptosis in a human hepatocellular carcinoma mouse model.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kiselyuk, A., Lee, S.H., Farber-Katz, S., et alHNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem. Biol. 19(7), 806-818 (2012).